AI predicting brain cancer relapse presents a groundbreaking advancement in pediatric oncology, especially for children suffering from gliomas.A recent study highlighted that an AI tool, leveraging temporal learning techniques, outperforms traditional methodologies in assessing cancer recurrence risk.